Catalyst Pharmaceuticals (CPRX) EPS (Basic) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.34% |
| Dec 31, 2025 | 31.35% |
| Sep 30, 2025 | 0.47% |
| Jun 30, 2025 | 36.72% |
| Mar 31, 2025 | 36.28% |
| Dec 31, 2024 | 41.88% |
| Sep 30, 2024 | 23.27% |
| Jun 30, 2024 | 26.05% |
| Mar 31, 2024 | 85.56% |
| Dec 31, 2023 | 34.23% |
| Sep 30, 2023 | -29.38% |
| Jun 30, 2023 | 51.57% |
| Mar 31, 2023 | 46.14% |
| Dec 31, 2022 | 43.10% |
| Sep 30, 2022 | 44.96% |
| Jun 30, 2022 | 44.04% |
| Mar 31, 2022 | 33.03% |
| Dec 31, 2021 | 30.60% |
| Sep 30, 2021 | 31.95% |
| Jun 30, 2021 | 31.95% |
| Mar 31, 2021 | 24.57% |
| Dec 31, 2020 | 28.99% |
| Sep 30, 2020 | 59.74% |
| Jun 30, 2020 | 28.47% |
| Mar 31, 2020 | 27.94% |
| Dec 31, 2019 | 29.20% |
| Sep 30, 2019 | 30.99% |
| Jun 30, 2019 | 33.24% |
| Mar 31, 2019 | 32.24% |
| Dec 31, 2018 | -36.08% |
| Sep 30, 2018 | 9.25% |
| Jun 30, 2018 | 5.59% |
| Mar 31, 2018 | -8.45% |
| Dec 31, 2017 | -88.07% |
| Sep 30, 2017 | 8.97% |
| Jun 30, 2017 | -37.97% |
| Mar 31, 2017 | -8.45% |
| Dec 31, 2016 | 12.94% |
| Sep 30, 2016 | 0.00% |
| Jun 30, 2016 | 0.00% |
| Mar 31, 2016 | 2.64% |
| Dec 31, 2015 | -11.84% |
| Sep 30, 2015 | 0.00% |